Risk of Post-Transplant De Novo Donor Specific Antibodies in Patients Receiving Transfusions Perioperatively

被引：0
|
作者：
Mahoney, I. [1 ]
Young, A. [1 ]
Shekiladze, N. [2 ]
Morris, A. [3 ]
Gupta, D. [3 ]
Bhatt, K. [3 ]
Laskar, S. [3 ]
Smith, A. [3 ]
Vega, J. [4 ]
Cole, R. T. [3 ]
机构：
[1] Emory Univ, Sch Med, Atlanta, GA USA
[2] Mem Hosp, Savannah, GA USA
[3] Emory Univ, Sch Med, Cardiol, Atlanta, GA USA
[4] Emory Univ, Sch Med, Cardiothorac Surg, Atlanta, GA USA
来源：
JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2018年 / 37卷 / 04期
关键词：
D O I：
10.1016/j.healun.2018.01.1099
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1096
引用
收藏
页码：S423 / S424
页数：2
相关论文
共 50 条
  • [21] Prevalence and Risk Factors for De Novo HLA Donor-Specific Antibodies in Adult Heart Transplant Recipients
    Goldraich, L. A.
    Alba, A. C.
    Ross, H. J.
    Tinckam, K.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2015, 34 (04): : S291 - S292
  • [22] De Novo HLA-DQ Donor Specific Antibodies Are Associated with a Higher Risk of Rejection and Transplant Glomerulopathy
    Willicombe, M.
    Santos-Nunez, E.
    Brookes, P.
    Roufosse, C.
    Cook, H. T.
    Galliford, J.
    Taube, D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 203 - 203
  • [23] De Novo Donor Specific Antibodies Are Associated with Antibody Mediated Rejection in Patients Receiving Alemtuzumab Induction.
    Willicombe, Michelle
    Brookes, Paul
    Galliford, Jack
    McLean, Adam
    Warrens, Anthony
    Cairns, Tom
    Taube, David
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 234 - 235
  • [24] The Clinical Spectrum Of De Novo Donor Specific Antibodies In Paediatric Renal Transplant Recipients
    Kim, Jon Jin
    Balasubramanian, Ramnath
    Michaelides, George
    Wittenhagen, Per
    Sebire, Neil
    Shaw, Olivia
    Vaughan, Robert
    Marks, Stephen
    PEDIATRIC NEPHROLOGY, 2014, 29 (09) : 1682 - 1682
  • [25] Treatment of De Novo Donor Specific Antibodies After Renal Transplant With IVIG.
    DeVos, J.
    Gaber, A.
    Patel, S.
    Islam, A.
    Teeter, L.
    Moore, L.
    Graviss, E.
    Skelton, A.
    Hong, D.
    Wolff, L.
    McGowan, C.
    Todd, E.
    Knight, R.
    TRANSPLANTATION, 2014, 98 : 138 - 138
  • [26] De Novo Donor Specific Antibodies in Pediatric Renal Transplant Recipients: Response to Therapy
    Tsai, E.
    Tzeng, J.
    Gjertson, D.
    Ettenger, R.
    Reed, E.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 443 - 443
  • [27] Correlation of Kidney Transplant Human Leukocyte Antigen Eplet Mismatching to De Novo Donor Specific Antibody Production and Post-Transplant Outcomes.
    Samudralwar, R.
    Szempruch, K.
    Reuter, C.
    Franz, B.
    Lee, R.
    Weimer, E.
    Detwiler, R.
    Kozlowski, T.
    Schmitz, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 768 - 768
  • [28] Treatment of De Novo Donor Specific Antibodies After Renal Transplant With IVIG.
    DeVos, J.
    Gaber, A.
    Patel, S.
    Islam, A.
    Teeter, L.
    Moore, L.
    Graviss, E.
    Skelton, A.
    Hong, D.
    Wolff, L.
    McGowan, C.
    Todd, E.
    Knight, R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 138 - 138
  • [29] What Stimulates the Development of De Novo Donor Specific Antibodies in Cardiac Transplant Recipients?
    Gupta, Richa
    Schlendorf, Kelly
    Fossey, Sallyanne
    Brinkley, Douglas M.
    Menachem, Jonathan N.
    Punnoose, Lynn R.
    Sacks, Suzanne Brown
    Ooi, Henry
    Wigger, Mark
    Zalawadiya, Sandip K.
    Lindenfeld, JoAnn
    JOURNAL OF CARDIAC FAILURE, 2019, 25 (08) : S170 - S170
  • [30] DE NOVO DONOR-SPECIFIC HLA ANTIBODIES: BIOMARKERS OF PANCREAS TRANSPLANT FAILURE
    Mittal, Shruti
    Page, Suzanne L.
    Gilbert, James
    Friend, Peter J.
    Sharples, Edward
    Fuggle, Susan V.
    TISSUE ANTIGENS, 2013, 81 (05): : 274 - 274
12345